1.

Record Nr.

UNINA9910437827103321

Titolo

Microdialysis in drug development / / Markus Muller, editor

Pubbl/distr/stampa

New York, : Springer, 2013

ISBN

1-283-62448-6

9786613936936

1-4614-4815-8

Edizione

[1st ed. 2013.]

Descrizione fisica

1 online resource (341 p.)

Collana

AAPS advances in the pharmaceutical sciences series, , 2210-7371

Altri autori (Persone)

MullerMarkus

Disciplina

615/.19

616.8/04754

Soggetti

Drug development

Brain microdialysis

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

pt. 1. General aspects -- pt. 2. Specific topics.

Sommario/riassunto

In vivo target site concentrations are probably the most important determinant of drug effects. Traditionally, linking drug concentrations to drug effects has been accomplished by modelling blood-derived data, mostly because a direct quantification of tissue concentrations has been beyond technical reach. Today, a direct measurement of target site concentrations is possible by employing microdialysis or complementary approaches such as imaging technologies. Microdialysis, initially conceived in the 1970ies, has become a standard tool in drug development. This comprehensive overview of current microdialysis technology covers general and disease-specific aspects of microdialysis by international experts in the field. It provides useful information for colleagues in academia and industry who are interested PK-PD aspects of drug development.